Source:http://linkedlifedata.com/resource/pubmed/id/16923522
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8 Suppl
|
pubmed:dateCreated |
2006-8-22
|
pubmed:abstractText |
FDG-PET imaging is more frequently being used to stage malignant Lymphoma and monitor response to therapy. However, FDG-PET is not a tumor specific substance and increased accumulation may be seen in a variety of benign entities, our case exemplifies this problem and underline the importance of a biopsy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1592-8721
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
91
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
ECR38
|
pubmed:meshHeading |
pubmed-meshheading:16923522-Fluorodeoxyglucose F18,
pubmed-meshheading:16923522-Hodgkin Disease,
pubmed-meshheading:16923522-Humans,
pubmed-meshheading:16923522-Neoplasm Staging,
pubmed-meshheading:16923522-Positron-Emission Tomography,
pubmed-meshheading:16923522-Radiopharmaceuticals,
pubmed-meshheading:16923522-Recurrence
|
pubmed:year |
2006
|
pubmed:articleTitle |
Pitfalls of positron emission tomography for assessing relapse in Hodgkin's disease: a case report.
|
pubmed:affiliation |
Department of 1Oncology, University of Messina, Italy. pitini@ciaoweb.it
|
pubmed:publicationType |
Journal Article
|